Synopsis
Plant Biodiversity - Evolutionary and Ecological Perspectives; T. Elmqvist. Chemodiversity and the Biological Role of Secondary Metabolites, Some Thoughts for Selecting Plant Material for Drug Development; R. Verpoorte. Evolving Strategies for the Selection, Dereplication and Prioritization of Antitumor and HIV-Inhibitory Natural Products Extracts; J.H. Cardellina II, et al. Screening Methods for Detection and Evaluation of Biological Activities of Plant Preparations; A.J. Vlietinck. The Use of Receptor Binding, a Very Specific, High Capacity Screening Method, in the Identification of Biologically Active Components from Natural Sources; M.Th.M. Tulp. Biological and Chemical Evaluation of Plant Extracts and Subsequent Isolation Strategy; A. Marston, K. Hostettmann. Natural Products with Antiprotozoal Activity; S.L. Croft, C.R. Weiss. In-Vitro Assays for Activity-Guided Enrichment of Immunomodulatory Plant Constituents; H. van Dijk, et al. Search for Potent Immunomodulatory Agents from Plants and Other Sources; H. Wagner. Cyclooxygenase and 5-Lipoxygenase as Targets for Medicinal Plant Research; R. Bauer. Natural Products in Drug Discovery and Development; W.N.A. Rolfsen Sandsborg. QPRI's System for Screening of Natural Products; R.J. Quinn. Phytera's Strategy for the Discovery of Novel Anti-Infective Agents from Plant Cell Cultures; J.B. McAlpine, et al. Expediting Drug Development Through the Use of Plants; P.J. Hylands. The Future Role of Natural Products in Drug Discovery; A.D. Buss. Index.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
